These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7267676

  • 1. Effect of nicotinic acid and dipyridamole on tissue blood flow in peripheral vascular disease.
    Smith RS, Warren DJ.
    Pharmatherapeutica; 1981; 2(9):597-600. PubMed ID: 7267676
    [Abstract] [Full Text] [Related]

  • 2. [Studies on the effect of nicotinic acid and adenosine monophosphate on skin and muscle circulation in healthy subjects and patients with peripheral circulatory disorders].
    Gottstein U, Felix R, Flad HD, Sedlmeyer I.
    Z Kreislaufforsch; 1966 Oct; 55(10):970-87. PubMed ID: 5994974
    [No Abstract] [Full Text] [Related]

  • 3. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI, Edvinsson ML, Angus Deveber G.
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [Abstract] [Full Text] [Related]

  • 4. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
    Klieber M, Resch F.
    Wien Klin Wochenschr; 1986 Feb 07; 98(3):70-3. PubMed ID: 2938341
    [Abstract] [Full Text] [Related]

  • 5. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
    Forconi S, Guerrini M, Agnusdei D, Di Perri T.
    Minerva Med; 1976 May 19; 67(25):1671-80. PubMed ID: 934519
    [No Abstract] [Full Text] [Related]

  • 6. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN.
    Med Sci Sports Exerc; 2003 Mar 19; 35(3):384-93. PubMed ID: 12618567
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial].
    Bopp J.
    Fortschr Med; 1976 Apr 22; 94(12):725-7. PubMed ID: 823084
    [Abstract] [Full Text] [Related]

  • 8. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
    Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V.
    Minerva Med; 1985 Feb 25; 76(7):269-75. PubMed ID: 3974940
    [Abstract] [Full Text] [Related]

  • 9. The effect of nicotinic acid on muscle blood flow in intermittent claudication measured with xenon-133 clearance method.
    Broomé A, Cederlund J, Eklöf B.
    Scand J Clin Lab Invest Suppl; 1967 Feb 25; 99():233-40. PubMed ID: 4862835
    [No Abstract] [Full Text] [Related]

  • 10. [MR-Imaging of lower leg muscle perfusion].
    Leppek R, Hoos O, Sattler A, Kohle S, Azzam S, Al Haffar I, Keil B, Ricken P, Klose KJ, Alfke H.
    Herz; 2004 Feb 25; 29(1):32-46. PubMed ID: 14968340
    [Abstract] [Full Text] [Related]

  • 11. Capillary neoformation in skeletal muscle of dipyridamole-treated rats.
    Tornling G, Adolfsson J, Unge G, Ljungqvist A.
    Arzneimittelforschung; 1980 Feb 25; 30(5):791-2. PubMed ID: 6156689
    [Abstract] [Full Text] [Related]

  • 12. Proliferative activity of capillary wall cells in skeletal muscle of rats during long-term treatment with dipyridamole.
    Tornling G, Unge G, Adolfsson J, Ljungqvist A, Carlsson S.
    Arzneimittelforschung; 1980 Feb 25; 30(4):622-3. PubMed ID: 7190403
    [Abstract] [Full Text] [Related]

  • 13. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
    Licata G, Pinto A, Parrinello G, Salli L, Indovina I.
    Clin Ter; 1985 Mar 31; 112(6):503-13. PubMed ID: 4017475
    [No Abstract] [Full Text] [Related]

  • 14. Vasodilator drugs in peripheral vascular disease.
    Coffman JD.
    J Maine Med Assoc; 1975 Oct 31; 66(10):262-9. PubMed ID: 1104731
    [No Abstract] [Full Text] [Related]

  • 15. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E, PISA (Persantin In Stable Angina) study group.
    Eur Heart J; 2001 Oct 31; 22(19):1785-93. PubMed ID: 11549300
    [Abstract] [Full Text] [Related]

  • 16. Effects of melatonin on the thermoregulatory responses to intermittent exercise.
    Atkinson G, Holder A, Robertson C, Gant N, Drust B, Reilly T, Waterhouse J.
    J Pineal Res; 2005 Nov 31; 39(4):353-9. PubMed ID: 16207290
    [Abstract] [Full Text] [Related]

  • 17. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.
    Ohashi S, Iwatani M, Hyakuna Y, Morioka Y.
    Arzneimittelforschung; 1985 Nov 31; 35(7A):1203-8. PubMed ID: 4074436
    [Abstract] [Full Text] [Related]

  • 18. Vascular effect of prostaglandin (PGE1) infused into the femoral artery in normals and patients with occlusive arterial disease.
    Nielsen PE, Holstein P, Nielsen SL, Poulsen HL.
    Bibl Anat; 1975 Nov 31; 13():305-6. PubMed ID: 1231765
    [No Abstract] [Full Text] [Related]

  • 19. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A, Rouffy J.
    J Mal Vasc; 1995 Nov 31; 20(1):21-7. PubMed ID: 7745355
    [Abstract] [Full Text] [Related]

  • 20. [Studies of the effectivity of blood vessel-active drugs with 133Xe muscle clearance].
    Zerkowitz A, Hoppe G, Bublitz G.
    Med Welt; 1969 Aug 09; 32():1736-40. PubMed ID: 5801059
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.